
US Veterans Affairs to replace Humira with biosimilar on national formulary
The U.S. Department of Veterans Affairs will be replacing Humira with the biosimilar Hadlima on its national formulary, as announced by Organon. Hadlima is a TNF inhibitor indicated for the treatment of various conditions and became the fourth FDA-approved biosimilar to Humira in 2019. The drug is available in a pre-filled syringe or an autoinjector,…